Hologic CEO gives glowing review to major stakeholder and activist investor Carl Icahn | Medtech Wall Street news for the week of August 4, 2014

Here's a look at some of the top Wall Street stories for medical device companies this week: Hologic's CEO praises its activist investor; Lantheus spikes IPO plans; Ex-CEO Pignatelli backs down, but not out, in spat with Biolase; Symmetry Medical sells its OEM biz to Tecomet for $450M; Valeant's hostile takeover hopes fade as Allergan war continues

Hologic's CEO praises its activist investor

August 4, 2014 by Arezu Sarvestani

Biolase Technology Inc., Hologic Inc., Lantheus Medical Imaging, Symmetry Medical Inc., Tecomet Inc., Valeant Pharmaceuticals, Allergan Inc.

News Well, Wall Street Beat

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/X4o6N7